CIPO Patents = 3

Forward Citations = 11

Loading Chart...

4 inventors (with patents filed for the assignee):

Kurt B Osther (7 out of 20 patents)

Gottfried H Kellermann (3 out of 3 patents)

Louis M Dyll (1 out of 2 patents)

4. Chung-Ho Hung (1 out of 4 patents)

7 patents: Sort by Forward Citations

1. 5830476 - Active induction or passive immunization of anti-Gp48 antibodies and (1998-11-03),

2. 5658569 - Anti-HIV-1 neutralizing antibodies (1997-08-19),

3. 5529776 - Anti-HIV-1 neutralizing antibodies (1996-06-25),

4. 5516895 - Antibodies specific towards gp 48 (1996-05-14),

5. 5286852 - Antibodies specific towards HIV-1 gp 48 (1994-02-15),

6. 5264342 - Method for determining the sensitivity and/or specificity of an assay (1993-11-23),

7. 5093230 - Method for rapid and sensitive detection of IgM retroviral antibodies (1992-03-03),

Verigen, Inc. is a biotechnology company focused on developing groundbreaking technologies for personalized cell therapies. With a team of experts in stem cell research and regenerative medicine, Verigen is dedicated to revolutionizing the field of cell therapy to help patients with various medical conditions. Their cutting-edge solutions aim to optimize the production of personalized cell therapies, making them more efficient and accessible to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#38 in Framingham, MA

#2,240 in Massachusetts

#38,762 in US

Framingham, MA, United States of America

Verigen, Inc.

Forward Citations = 11

4 inventors:

Kurt B Osther (7 out of 20 patents)

Gottfried H Kellermann (3 out of 3 patents)

Louis M Dyll (1 out of 2 patents)

4. Chung-Ho Hung (1 out of 4 patents)

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com